JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

HIV Integrase

C4787 Equisetin

Summary: HIV-1 integrase inhibitor

Soluble in DMSO;Soluble in dimethyl formamide
B5856 GSK1349572 sodiuM salt

Summary: Next-generation HIV integrase (IN) inhibitor

insoluble in H2O; insoluble in EtOH; ≥8.06 mg/mL
B1122 Nelfinavir

Summary: HIV-1 protease inhibitor

insoluble in H2O; ≥16.1 mg/mL
A8566 GSK744 (S/GSK1265744)

Summary: HIV integrase inhibitor, oral active and long-acting

insoluble in H2O; insoluble in EtOH; ≥19.35 mg/mL
A4074 S/GSK1349572

Summary: HIV integrase inhibitor, novel and potent

≥41.9 mg/mL
A4073 Raltegravir (MK-0518)
1 Citation

Target: integrase

Summary: HIV-1 integrase inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.95 mg/mL
A4072 MK-2048

Summary: Integrase inhibitor for HIV-1,second generation

≥10.55 mg/mL

insoluble in H2O
A4071 Fluorouracil (Adrucil)
12 Citation

Target: Thymidylate Synthase

Summary: Antitumor agent;inhibitor of thymidylate synthase

insoluble in EtOH; ≥10.04 mg/mL
A4070 Elvitegravir (GS-9137)

Target: HIV Integrases

Summary: HIV-1 integrase inhibitor,potent

insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL
A4069 BMS-707035

Target: HIV Integrases

Summary: HIV-I integrase inhibitor,potent and specific

insoluble in EtOH; insoluble in H2O; ≥41 mg/mL